The anesthetic action of some polyhalogenated ethers - Monte Carlo method based QSAR study

Up to this date, there has been an ongoing debate about the mode of action of general anesthetics, which have postulated many biological sites as targets for their action. However, postoperative nausea and vomiting are common problems in which inhalational agents may have a role in their development. When a mode of action is unknown, QSAR modelling is essential in drug development. To investigate the aspects of their anesthetic, QSAR models based on the Monte Carlo method were developed for a set of polyhalogenated ethers. Until now, their anesthetic action has not been completely defined, although some hypotheses have been suggested. Therefore, a QSAR model should be developed on molecular fragments that contribute to anesthetic action. QSAR models were built on the basis of optimal molecular descriptors based on the SMILES notation and local graph invariants, whereas the Monte Carlo optimization method with three random splits into the training and test set was applied for model development. Different methods, including novel Index of ideality correlation, were applied for the determination of the robustness of the model and its predictive potential. The Monte Carlo optimization process was capable of being an efficient in silico tool for building up a robust model of good statistical quality. Molecular fragments which have both positive and negative influence on anesthetic action were determined. The presented study can be useful in the search for novel anesthetics.

[1]  A. Toropova,et al.  The Monte Carlo technique as a tool to predict LOAEL. , 2016, European journal of medicinal chemistry.

[2]  N. Franks.  General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal , 2008, Nature Reviews Neuroscience.

[3]  E Benfenati,et al.  CORAL: building up the model for bioconcentration factor and defining it's applicability domain. , 2011, European journal of medicinal chemistry.

[4]  K. Roy,et al.  Be aware of error measures. Further studies on validation of predictive QSAR models , 2016 .

[5]  Kunal Roy,et al.  Comparative QSARs for antimalarial endochins: Importance of descriptor-thinning and noise reduction prior to feature selection , 2011 .

[6]  A. Pohorille,et al.  Hypothesis: volatile anesthetics produce immobility by acting on two sites approximately five carbon atoms apart. , 1999, Anesthesia and analgesia.

[7]  R. Eckenhoff,et al.  Molecular interactions between inhaled anesthetics and proteins. , 1997, Pharmacological reviews.

[8]  K. Miller,et al.  Mechanisms of actions of inhaled anesthetics. , 2003, The New England journal of medicine.

[9]  H. Kubinyi.  QSAR and 3D QSAR in drug design Part 2: applications and problems , 1997 .

[10]  Paola Gramatica,et al.  Principles of QSAR models validation: internal and external , 2007 .

[11]  Aleksandar M Veselinović,et al.  Application of SMILES Notation Based Optimal Descriptors in Drug Discovery and Design. , 2015, Current topics in medicinal chemistry.

[12]  E. Eger,et al.  Polyhalogenated methyl ethyl ethers: solubilities and anesthetic properties. , 1999, Anesthesia and analgesia.

[13]  N. P. Franks,et al.  Molecular mechanisms of general anaesthesia , 1982, Nature.

[14]  Andrey A Toropov,et al.  The index of ideality of correlation: A criterion of predictive potential of QSPR/QSAR models? , 2017, Mutation research.

[15]  G. Mangiatordi,et al.  Applicability Domain for QSAR models: where theory meets reality , 2016 .

[16]  A. Toropova,et al.  QSAR as a random event: a case of NOAEL , 2015, Environmental Science and Pollution Research.

[17]  Paola Gramatica,et al.  A Historical Excursus on the Statistical Validation Parameters for QSAR Models: A Clarification Concerning Metrics and Terminology , 2016, J. Chem. Inf. Model..

[18]  Peixun Liu,et al.  Current Mathematical Methods Used in QSAR/QSPR Studies , 2009, International journal of molecular sciences.

[19]  Henrik Kehlet,et al.  Anaesthesia, surgery, and challenges in postoperative recovery , 2003, The Lancet.

[20]  Tomasz Arodz,et al.  Computational methods in developing quantitative structure-activity relationships (QSAR): a review. , 2006, Combinatorial chemistry & high throughput screening.

[21]  S. Diao,et al.  Mechanisms of action of general anesthetics. , 2014, Frontiers in bioscience.

[22]  J L Robinson,et al.  The stereospecific effects of isoflurane isomers in vivo. , 1994, European journal of pharmacology.

[23]  Kunal Roy,et al.  On some aspects of validation of predictive quantitative structure–activity relationship models , 2007, Expert opinion on drug discovery.

[24]  A. Mehdipour,et al.  QSAR Studies on the Anesthetic Action of Some Polyhalogenated Ethers , 2007, Chemical biology & drug design.

[25]  Danishuddin,et al.  Descriptors and their selection methods in QSAR analysis: paradigm for drug design. , 2016, Drug discovery today.

[26]  Chartchalerm Isarankura-Na-Ayudhya,et al.  A practical overview of quantitative structure-activity relationship , 2009 .

[27]  N. Franks,et al.  Molecular targets underlying general anaesthesia , 2006, British journal of pharmacology.

[28]  Alexander Tropsha,et al.  Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research , 2010, J. Chem. Inf. Model..

[29]  B. Antkowiak.  How do general anaesthetics work? , 2001, Naturwissenschaften.

[30]  Alexander Tropsha,et al.  Best Practices for QSAR Model Development, Validation, and Exploitation , 2010, Molecular informatics.

[31]  D. Sokolović,et al.  QSAR study of 2,4-dihydro-3H-1,2,4-triazol-3-ones derivatives as angiotensin II AT1 receptor antagonists based on the Monte Carlo method , 2018, Structural Chemistry.

[32]  S. Forman.  Molecular approaches to improving general anesthetics. , 2010, Anesthesiology clinics.